Baseline characteristics that influence “off” time improvement in levodopa-carbidopa intestinal gel-treated advanced Parkinson’s disease patients in the GLORIA registry

W. Poewe; L. Bergmann; A. Yegin; W. Robieson; A. Antonini

首页> 外文期刊>Journal of the Neurological Sciences: Official Bulletin of the World Federation of Neurology >Baseline characteristics that influence “off” time improvement in levodopa-carbidopa intestinal gel-treated advanced Parkinson’s disease patients in the GLORIA registry

【24h】

Baseline characteristics that influence “off” time improvement in levodopa-carbidopa intestinal gel-treated advanced Parkinson’s disease patients in the GLORIA registry

机译：基线特征，影响Levodopa-Carbidopa肠凝胶治疗的高级帕金森病患者在Gloria注册表中

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《Journal of the Neurological Sciences: Official Bulletin of the World Federation of Neurology》 |2017年第2017期|共1页
作者
W. Poewe; L. Bergmann; A. Yegin; W. Robieson; A. Antonini;
展开▼
作者单位

Medical University of Innsbruck;

AbbVie Inc Global Medical Affairs;

AbbVie Inc Global Medical Affairs;

AbbVie Inc Global Medical Affairs;

University of Padua;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类神经病学;
关键词

相似文献

外文文献
中文文献
专利

1. Baseline characteristics that influence “off” time improvement in levodopa-carbidopa intestinal gel-treated advanced Parkinson’s disease patients in the GLORIA registry [J] . W. Poewe, L. Bergmann, A. Yegin, Journal of the Neurological Sciences: Official Bulletin of the World Federation of Neurology . 2017,第期

机译：基线特征，影响Levodopa-Carbidopa肠凝胶治疗的高级帕金森病患者在Gloria注册表中
2. Non-motor symptoms (nms) improvement is correlated with baseline nms burden and improved quality of life (QoL) in levodopa-carbidopa intestinal gel (LCIG) treated parkinson’s disease patients [J] . K.R. Chaudhuri, W. Poewe, L. Bergmann, Journal of the Neurological Sciences: Official Bulletin of the World Federation of Neurology . 2017,第期

机译：非运动症状（NMS）改善与基线NMS负担相关，提高左旋多巴肠道肠凝胶（LCIG）治疗帕金森病患者的生活质量（QOL）
3. Improvement of impulse control disorders associated with levodopa-carbidopa intestinal gel treatment in advanced Parkinson's disease [J] . Jose Catalan Maria, Antonio Molina-Arjona Jose, Mir Pablo, Journal of neurology . 2018,第6期

机译：高达帕金森病中左旋多巴肠肠凝胶治疗脉冲控制障碍的改善
4. A decision support system based on rapid progression rules to enhance baseline evaluation of Parkinson's disease patients [C] . Kostas M. Tsiouris, Dimitrios Gatsios, Georgios Rigas, IEEE EMBS International Conference on Biomedical and Health Informatics . 2018

机译：基于快速进展规则的决策支持系统，可增强帕金森氏病患者的基线评估
5. A longitudinal study of fetal tissue transplantation surgery for the treatment of Parkinson's disease: Can quality of life and optimism at baseline predict patient outcome 10 years later? [D] . Fazio, Emily B. 2011

机译：胎儿组织移植手术治疗帕金森氏病的纵向研究：基线时的生活质量和乐观情绪能否预测10年后的患者预后？
6. Predictors of Response for Off Time Improvement With Levodopa-Carbidopa Intestinal Gel Treatment: An Analysis of the GLORIA Registry [O] . Werner Poewe, Lars Bergmann, Weining Z. Robieson, 2020

机译：左旋多巴肠肠凝胶治疗关时间改进的响应预测因素：Gloria注册机构的分析
7. Long-term effectiveness of levodopa-carbidopa intestinal gel on motor and non-motor symptoms in advanced Parkinson’s disease: results of the Italian GLORIA patient population [O] . Angelo Antonini, Pietro Marano, Graziano Gusmaroli, 2020

机译：左旋多巴 - 肉豆盆肠凝胶对高级帕金森病的长期有效性，在高级帕金森病中的症状：意大利格洛丽亚患者人口的结果

Baseline characteristics that influence “off” time improvement in levodopa-carbidopa intestinal gel-treated advanced Parkinson’s disease patients in the GLORIA registry

著录项

引文网络

相似文献

相关主题

期刊订阅